Xanthonychia Due to Staining From Carbidopa-Levodopa

Xanthonychia Due to Staining From Carbidopa-Levodopa

Authors

  • Jonathan Kyle Hwang Weill Cornell Medicine, New York, USA
  • Shari Lipner Weill Cornell Medicine, New York, USA

References

Vignes S, Baran R. Yellow nail syndrome: a review. Orphanet J Rare Dis. 2017;12(1):42. Published 2017 Feb 27. doi:10.1186/s13023-017-0594-4

Anang JBM. Levodopa-Carbidopa-Related Rash in Parkinson's Disease: A Case Series. Can J Neurol Sci. 2018;45(5):588-589. doi:10.1017/cjn.2018.58

Downloads

Published

2023-07-31

Issue

2023 Vol 13, No 3 | July

Section

Image Letter

License

Copyright (c) 2023 Jonathan Hwang, Shari Lipner

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.

How to Cite

1.
Hwang JK, Lipner S. Xanthonychia Due to Staining From Carbidopa-Levodopa. Dermatol Pract Concept. 2023;13(3):e2023157. doi:10.5826/dpc.1303a157

Share

Crossref
Scopus
Google Scholar
Europe PMC